Product Details
Addiction in Chronic Pain Patients: How to Know and What to Do
- Credit(s): 0.75 AMA PRA Category 1 Credits™ (Enduring), 0.75 DEA SUD, 0.75 ETHICS
- Course Number: PME-TMADCT/GEN
- Duration: 47 minutes
- Access: Available until November 10, 2025
On Demand Webinar
- Non-Member Price
- $149.00
- Member Price
- $0.00

Description

This program is eligible to count towards federal and/or state mandated trainings.*

Addiction doesn’t care about specialty, a patient with addiction can be any patient. This session will cover how to identify substance-use disorders in pain patients and discuss the basics of safe management for the patient and your practice.

Best Bits

How to tell who has a substance use disorder
What is multimodal treatment?
What to do if you keep or refer an addicted patient

Learning Objectives
Upon completion of this activity, participants will be able to:

Review what is addiction;
Identify warning signs of addiction; and
Discuss ways to treat addiction to appropriately manage chronic pain patients with addiction.

Competencies
This program addresses the following desirable physician attributes: Interprofessional Communication, Provide Patient Center Care, and Professionalism.

*Meeting Mandated CME Requirements
This program is eligible to count towards: (i) the eight hours of training on treatment and management of patients with opioid or other substance use disorders required for all U.S. Drug Enforcement Administration-registered practitioners, and (ii) the two hours of CME in the study of pain management and the prescribing and monitoring of controlled substances required by the Texas Medical Board.

This program will address the TMB specified topics of:

Best practices, alternative treatment options, and multimodal approaches to pain management that may include physical therapy, psychotherapy, and other treatments;
Safe and effective pain management related to the prescription of opioids and other controlled substances, including education regarding:
- Standards of care;
- Identification of drug-seeking behavior in patients; and
- Effectively communicating with patients about the prescription of an opioid or other controlled substances.

Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.

Recorded: April 30, 2022
Released: Nov. 10, 2022
Expires: Nov. 10, 2025

Return Policy
No refunds or exchanges will be processed for this program.

Credits

0.75 AMA PRA Category 1 Credits™ (Enduring)
The Texas Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Texas Medical Association designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

On select courses, the Texas Medical Association requires physician to complete 70-percent of the test questions correctly to receive credit for this course.

See TMA’s Web Site Privacy Statement

0.75 DEA SUD The Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders. This program is eligible to count towards the training requirement. Participation in this program in no way implies the participant has fully met the federally and state-mandated training requirements. Participants are solely responsible for ensuring any mandated training requirements are completed.

0.75 ETHICS
This course has been designated for 0.75 credit(s) of education in medical ethics and/or professional responsibility.

Faculty

Michael P. Sprintz, DOBio

Michael P. Sprintz, DO Bio

Dr. Michael Sprintz is a national expert on addiction and chronic pain. He trained at the prestigious Johns Hopkins Hospital and MD Anderson Cancer Center and is triple board-certified in Addiction Medicine, Pain Medicine, and Anesthesiology.

Dr. Sprintz is personally in recovery from opioid and alcohol addiction for over 20 years. After getting sober, he found his calling in helping patients with pain and addiction and established himself as one of the pioneers in his field. In 2013, he founded the Sprintz Center for Pain and Recovery in The Woodlands, TX. The innovative practice was one of the first private pain and addiction treatment programs in the country. Dr. Sprintz has also married patient care with technology by founding Cellarian. This software was created to empower clinical decision-making support by providing visualizations, medical documentation, and data analysis in real time. His story of overcoming addiction, his professional expertise, his charisma, humor and authenticity make him a valuable personality to engage, entertain, inform and inspire a global audience.

A passionate and engaging public speaker, entrepreneur, and author, Dr. Sprintz is an experienced, entertaining, and authentic speaker and consultant. Who better than an addict, to change how the world understands addiction?

Materials

Slide Handout PDF (20) (1 MB)

Desktop Site